Searchable abstracts of presentations at key conferences in endocrinology

ea0037gp.05.07 | Developmental and paediatric endocrinology | ECE2015

Prediction of affective disorders in adult men on the basis of steroid profiling

Hill Martin , Ripova Daniela , Mohr Pavel , Velikova Marta , Bicikova Marie , Duskova Michaela , Starka Luboslav

A number of evidence indicate that mood (affective) disorders are influenced by various bioactive steroids such as corticoids, sex hormones and neuroactive steroids. However, to date, there are limited data concerning the discrimination between patients suffering from the disorders and controls, or regarding the classification of individual subtypes of mood disorders on the basis of steroid profiling. Therefore 47 steroids including their conjugates and further related substan...

ea0035p956 | Steroid metabolism and action | ECE2014

Profiling of neuroactive steroids, their precursors and metabolites in patients suffering from multiple sclerosis

Kancheva Radmila , Hill Martin , Kancheva Lyudmila , Velikova Marta , Pavelcova Miluse , Starka Luboslav , Havrdova Eva

Some steroids modulate the permeability of ionotropic receptors on cell membranes and therefore may activate or inhibit neuronal activity depending on the steroid structure. These neuroactive steroids (NAS) exert neuroprotective effects like the neuronal remyelination.Multiple sclerosis (MS) is the most common cause of neurological disability in young adults. Therefore, the authors have followed the neuroprotective, GABAergic, glycinergic, glutamatergic ...

ea0037ep51 | Adrenal cortex | ECE2015

Comparison of 17-OH progesterone response to various dose of tetracosactide

Kosak Mikulas , Duskova Michaela , Simunkova Katerina , Hana Vaclav , Krsek Michal , Jandikova Hana , Pospisilova Hana , Sramkova Monika , Velikova Marta , Starka Luboslav

ACTH test is widely accepted as diagnostic tool in suspicion on peripheral as well as on central hypocorticism. The optimal dose of tetracosactide for determination of hypocorticism is still matter of debate. The 250 μg as a standard dose of tetracosactide has been approved for diagnosis of congenital adrenal hyperplasia (CAH) many years ago. Moreover, current limited availability of tetracosactide and its increased financial cost on the market raised the question whether...